Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)
Biomarker and diagnostic research for thyroid gland papillary and follicular carcinoma has been reported in the published literature.
No clinical trials have been registered for thyroid gland papillary and follicular carcinoma.
217 publications have been identified in PubMed for thyroid gland papillary and follicular carcinoma. Kisho has analyzed 131 by research type. Research spans Review / Meta-Analysis (30%), Diagnostic / Biomarker (19%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 39 | 30% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:34 PM UTC
Testing and diagnosis research |
25 |
19% |
Laboratory research | 24 | 18% |
Patient case studies | 22 | 17% |
Disease patterns and progression | 13 | 10% |
Other research | 3 | 2% |
Clinical study results | 3 | 2% |
New treatment approaches | 2 | 2% |
Ashorobi D (2026). [PMID: 30969597](https://pubmed.ncbi.nlm.nih.gov/30969597/). *Unknown Journal*. [Review / Meta-Analysis]
Zou M (2026). [PMID: 41808291](https://pubmed.ncbi.nlm.nih.gov/41808291/). *Autoimmunity*. [Basic Science / Preclinical]
Allen E (2026). [PMID: 29262169](https://pubmed.ncbi.nlm.nih.gov/29262169/). *Unknown Journal*. [Other]
Ohori NP (2026). [PMID: 42018436](https://pubmed.ncbi.nlm.nih.gov/42018436/). *Cancer Cytopathol*. [Review / Meta-Analysis]
Menon G (2026). [PMID: 30844206](https://pubmed.ncbi.nlm.nih.gov/30844206/). *Unknown Journal*. [Review / Meta-Analysis]
Boutzios G (2026). [PMID: 41348279](https://pubmed.ncbi.nlm.nih.gov/41348279/). *Hormones (Athens)*. [Epidemiology / Natural History]
Li JZ (2026). [PMID: 41701943](https://pubmed.ncbi.nlm.nih.gov/41701943/). *Clin Cancer Res*. [Diagnostic / Biomarker]
Ruz-Caracuel I (2026). [PMID: 41747300](https://pubmed.ncbi.nlm.nih.gov/41747300/). *Rev Esp Patol*. [Review / Meta-Analysis]
Bagasariya R (2026). [PMID: 42049458](https://pubmed.ncbi.nlm.nih.gov/42049458/). *J Nucl Med Technol*. [Epidemiology / Natural History]
Lee K (2026). [PMID: 29083690](https://pubmed.ncbi.nlm.nih.gov/29083690/). *Unknown Journal*. [Review / Meta-Analysis]